Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003162 · ClinicalTrials.gov registry record · Phase 3
Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
A Phase 3 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 949
- Enrollment target
NCT00003162 is a Phase 3 study that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 949 participants.
The verdict
NCT00003162, a Phase 3 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 949 participants
- Enrollment target
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective for bone metastases. PURPOSE: Randomized phase III trial to compare different radiation therapy regimens in treating patients who have bone metastases from breast or prostate cancer.
Interventions
- RADIATION radiation therapy
- PROCEDURE pain therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 949 participants |
| Start Date | 1998-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003162
The ClinicalTrials.gov registry entry for NCT00003162 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 949 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which radiation therapy is the first listed.
NCT00003162 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003162 about?
NCT00003162 is a clinical study titled "Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective for bone metastases. PURPOSE: Randomized phase III trial to compare different radiation therapy regimens in treating patients who have bone metastases fr...
What is the current status of trial NCT00003162?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 949 participants. The study started on 1998-02.
What interventions are being tested in trial NCT00003162?
The interventions under investigation include: radiation therapy (RADIATION), pain therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00003162?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.